# FDA Inspection 751102 - Recipharm Stockholm AB - September 09, 2011

Source: https://www.globalkeysolutions.net/records/fda_inspections/recipharm-stockholm-ab/ffc3b864-d895-4e89-ab16-c689448af0d4
Source feed: FDA_Inspections

> FDA Inspection 751102 for Recipharm Stockholm AB on September 09, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 751102
- Company Name: Recipharm Stockholm AB
- Inspection Date: 2011-09-09
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1108013 - 2019-06-05](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-stockholm-ab/29f2bdb0-59b2-4258-9c82-f983ef2c6459)
- [FDA Inspection 874929 - 2014-03-11](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-stockholm-ab/95a06dff-5037-4f78-86fe-7f9525aeb8c9)
- [FDA Inspection 869336 - 2014-03-11](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-stockholm-ab/d71e251f-25b2-4942-a83d-92b3000e0887)
- [FDA Inspection 749107 - 2011-09-08](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-stockholm-ab/1d8a2801-e776-4317-bc4b-86e065e19fce)

Company: https://www.globalkeysolutions.net/companies/recipharm-stockholm-ab/1c17c35b-63d2-4c56-a727-c5cce9a8e186

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c